Company: BNBX
Filing Date: 2025-02-11
Form Type: DEFA14A
Source: 0001104659-25-011231
Chunk: 1

Company: BNB PLUS CORP.
Filing Date: 2025-02-11
Form: DEFA14A
Chunk 1
---
 at.

The Special Meeting was originally held on January 23, 2025, but, due to a lack of quorum, was adjourned to allow additional time for the Company’s stockholders to vote on Proposal One (the “Warrant Exercise Proposal”) set forth in the Company’s definitive proxy statement (the “Proxy Statement”) filed with the U.S. Securities and Exchange Commission on: to approve, in accordance with Nasdaq Listing Rule 5635(d), the exercisability of certain common stock purchase warrants, and the issuance of the common stock underlying such warrants, which warrants were issued in connection with an offering of securities of the Company that occurred on October 30, 2024.

About Applied DNA Sciences

Applied DNA Sciences is a biotechnology company
developing technologies to produce and detect deoxyribonucleic acid (“DNA”). Using the polymerase chain reaction (“PCR”)
to enable both the production and detection of DNA, we currently operate in three primary business markets: (i) the enzymatic manufacture
of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase
(“RNAP”) for use in the production of mRNA therapeutics; (ii) the detection of DNA and RNA in molecular diagnostics and genetic
testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.

Visit for more information. Follow us on
and . Join our .

| YOUR VOTE IS IMPORTANT!                                                                                                               
 Your vote is important, and we ask that you please vote “FOR” the                                                                     
 Warrant Exercise Proposal.                                                                                                            
 For specific instructions on how to vote your shares, please refer                                                                    
 to the instructions on the Notice of Internet Availability of Proxy Materials you received in the mail, the section entitled “About   
 the Special Meeting” beginning on page 1 of the Proxy Statement or, if you request to receive printed proxy materials, your           
 enclosed proxy card. Please note that shares held beneficially in street name may be voted by you in person at the Special Meeting    
 only if you obtain a legal proxy from the broker, bank, trustee, or other nominee that holds your shares giving you the right to vote 
 the shares.                                                                                                                           
 If you have any questions or require any assistance with voting                                                                       
 your shares, please call the Company’s proxy solicitor, Kingsdale Advisors, at:                                                       
 1- 855-682-9644 (toll free) or